Xponance Inc. Has $10.61 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Xponance Inc. boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 35,361 shares of the company’s stock after buying an additional 542 shares during the quarter. Xponance Inc.’s holdings in HCA Healthcare were worth $10,614,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at $39,000. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare during the 4th quarter worth $31,000. Tidemark LLC acquired a new stake in HCA Healthcare during the 4th quarter worth $36,000. Activest Wealth Management increased its holdings in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. increased its holdings in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on HCA shares. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Truist Financial dropped their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Barclays dropped their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Finally, Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $400.00 to $320.00 in a research note on Monday, November 25th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $329.97 on Wednesday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The stock has a market cap of $81.24 billion, a price-to-earnings ratio of 15.02, a P/E/G ratio of 1.10 and a beta of 1.68. The company’s fifty day moving average is $320.07 and its 200 day moving average is $344.03.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the business earned $5.90 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.